Profile Image

Staff Profile

Edit

Career Summary

Biography

Carolyn Mountford is Professor in Radiology at the University of Newcastle, Australia, and full Professor of Radiology at the Harvard Medical School, USA. She is Director of the Centre for MR in Health in Newcastle and Director of the Centre for Clinical Spectroscopy at the Brigham and Women's Hospital in Boston MA.

 

Qualifications

  • Doctor of Philosophy, University of Oxford - UK, 31/12/1978
  • Master of Science (Biophysics), University of Oxford - UK, 31/12/1976

Research

Research keywords

  • Cancer
  • Head Injury
  • MR Imaging and Spectroscopy
  • Post Traumatic Stress Disorder

Research expertise

Professor Carolyn Mountford is a world-leading expert in magnetic resonance (MR) spectroscopy. An advocate of multidisciplinary research, she has spent the last three decades working with scientists, physicians, surgeons, mathematicians, pathologists and engineers initially developing MR as an adjunct to, and in some cases a replacement for, histopathology.

The team, led by Professor Mountford, has identified early stages of human cancers not detectable by conventional methods such as light microscopy. She has pioneered the development and application of many novel in vivo MR techniques to measure metabolic changes associated with tumour development and progression. The analysis of a primary breast tumour alone can predict if the tumour has spread to the nodes, removing the need for surgical intervention.

A new in vivo MR approach known as neuro two dimensional spectroscopy has provided an objective test for chronic pain, head injury and post traumatic stress disorder. This has allowed hitherto undetected changes to brain chemistry to be identified, leading to potential new therapies.

These and other techniques her team has developed are being used by research centres and hospitals to evaluate patients with cancer, brain tumours and neurologic and psychological disorders. The technology has been taken on by the USA and Australian militaries for assessment of soldiers. The same two dimensional spectroscopy methodologies have allowed the recent discovery of a new condition in the breast tissue of women who carry the faulty BRCA genes.

Her team has been the worldwide development site for Siemens Healthcare for MR spectroscopy since 1999. Across 2006-2011, while at Harvard Medical School full time, Professor Mountford worked with Siemens to develop an improved operating system for its scanners, allowing spectroscopy to be undertaken by a trained radiographer as opposed to a highly trained physicist. This has made the previously site-dependent MR spectroscopy technology available worldwide. Three of her past students are now in senior development roles at Siemens (Germany) and GE (USA). Others are surgeons or academics.

She is currently working with Canadian and UK-based teams to produce a pathology MR spectroscopy system, with pattern recognition technology, to allow the biopsy program to go mainstream in a clinical capacity. Professor Mountford is the holder of five significant patents (USA & worldwide) in the areas of cancer, chronic pain, head injury and MR technological advances. A further five are currently in the PCT phase.

Current goals include: a new objective and personalised medicine approach for soldiers and the general public afflicted by head injury, post traumatic stress disorder, blast injury and chronic pain; the capability for screening women at high risk for breast cancer to diagnose early changes that reflect a microenvironment for rapid tumour growth; understanding how brain chemistry affects the gut; seeing MR spectroscopy on biopsy become a mainstream diagnostic text worldwide; and educating and encouraging young Australian early career researchers to become part of the flourishing international and commercial interface.

Fields of Research

CodeDescriptionPercentage
110320Radiology And Organ Imaging50
110904Neurology And Neuromuscular Diseases25
111200Oncology And Carcinogenesis25

Memberships

Body relevant to professional practice.

  • Member - Australian Science, Technology and Engineering Council
  • Management of Research and Ethics on Australia's World Heritage Areas
  • Member - Federation of Australian Scientific and Technological Societies
  • Member - Society for Magnetic Resonance in Medicine
  • Member - International Society for Magnetic Resonance in Medicine
  • Member - Radiological Society of North America
  • Member - International Society of Magnetic Resonance

Committee/Associations (relevant to research).

  • Member - Ministerial Advisory Group, Science and Technology Awareness and Promotion

Editorial Board.

  • Member - Journal of Magnetic Resonance in Medicine
  • Member - Journal of Magnetic Resonance
  • Member - Magnetic Resonance in Medical Sciences
  • Member - MAGMA

Appointments

Honorary Clinical Professorial Fellow
Royal Melbourne Hospital (Australia)
01/01/2006 - 01/01/2014
Honorary Member
Department of Surgery, University of Sydney (Australia)
01/01/1995 - 01/12/2006
Honorary Scientist
Institute for Biodiagnostics (Canada)
01/01/1998 - 01/12/2012
Foundation Chief Executive
Institute for Magnetic Resonance Research (Australia)
01/01/1995 - 01/12/2006
Foundation Head
Department of Magnetic Resonance in Medicine (Australia)
01/01/1998 - 01/12/2006
Director of Clinical Spectroscopy
Brigham and Women's Hospital, Boston MA, USA (United States)
01/01/2007

Awards

Honours.

2013Thought Leader Award
Aglient Technologies (United States)
Moving MR in pathology into the Clinic
2008Excellence Award
Brigham and Woman's Hospital, Harvard Medical School (United States)
Partners in Excellence
1996Graham Coupland Award
Royal Australasian College of Surgeons (Australia)
Detection of cancers by MRS that are not observable by light microscopy

Recognition.

1994Inaugural 'Unsung Hero of Science' Award
Australian Association of Science Communicators (Australia)
Early Detection of Cancer
1990Fellowship
International Society for Magnetic Resonance in Medicine (Australia)
Contribution to the Society

Research Award.

2013Excellence in Innovation Award
Newcastle Innovation (Australia)
Professor Carolyn Mountford is a world recognised authority on Magnetic Resonance Spectroscopy (MRS). She holds a number of global patents on techniques used in MRS and her work has played a significant role in detecting early stage cancer using non-invasive methods.
1998Clinical Centre of Excellence Award
Australian National Health and Medical Research Council (Australia)
Teaching MR in Medicine
1997Inaugural 'Pioneer of Hope' Award
NSW Cancer Council (Australia)
Breast Cancer Detection using MRS
1996Innovation Flagship Award
Australian Government/NSW Government (Australia)
Magnetic Resonance in Medicine

Invitations

Development of MRS as an Adjunct to Hisopathology
Third National NMR Conference, Australia (Invited Presenter)
1981
Development of MRS as an Adjunct to Hisopathology
Australian Biophysics Society, Australia (Invited Presenter)
1982
Development of MRS as an Adjunct to Hisopathology
NMR of Synthetic and Biological Polymers, Australia (Invited Presenter)
1982
Development of MRS as an Adjunct to Hisopathology
Australian Biophysics Society, Australia (Invited Presenter)
1983
Development of MRS as an Adjunct to Hisopathology
Treatment of Cancer in Adults, Australia (Invited Presenter)
1984
Development of MRS as an Adjunct to Hisopathology
Australian Colposcopy and Cervical Pathology, Australia (Invited Presenter)
1992
Development of MRS as an Adjunct to Hisopathology
11th Annual Cytology Meeting, Australia (Keynote Address)
1992
Development of MRS as an Adjunct to Hisopathology
Royal Australian Chemical Institute Annual Meeting, Australia (Keynote Address)
1992
Development of MRS as an Adjunct to Hisopathology
Australian Institute of Medical Scientists, National Scientific Meeting, Australia (Invited Presenter)
1993
Development of MRS as an Adjunct to Hisopathology
XV International Congress of Clinical Chemistry, Australia (Invited Presenter)
1993
Development of MRS as an Adjunct to Hisopathology
Royal Australian College of Surgeons Annual Meeting, Australia (Invited Presenter)
1993
Magnetic Resonance Spectroscopy in the Clinic
International Society of Magnetic Resonance, Australia (Invited Presenter)
1995
Magnetic Resonance Spectroscopy in the Clinic
9th World Congress of Cervical Pathology and Colposcopy, Australia (Invited Presenter)
1996
Magnetic Resonance Spectroscopy in the Clinic
CSIRO XXX Colloquium Spectroscopicum Internationale, Australia (Invited Presenter)
1997
Magnetic Resonance Spectroscopy in the Clinic
International Conference on Chemotherapy, Australia (Invited Presenter)
1997
Science in the Classroom
CONASTA 41 Annual Conference of Australian Science Teachers, Australia (Keynote Address)
1992
Science in the Classroom
Science Mapping the Possible Future, Australia (Invited Presenter)
1993
Preoperative Diagnosis of Cancer by Magnetic Resonance Spectroscopy
6th Scientific Meeting, International Society for Magnetic Resonance in Medicine, Australia (Invited Presenter)
1998
Preoperative Diagnosis of Cancer by Magnetic Resonance Spectroscopy
Institute for Magnetic Resonance Research and Hunting Research Institute, Australia (Keynote Address)
1998
Preoperative Diagnosis of Cancer by Magnetic Resonance Spectroscopy
Australasian Society of Breast Disease, Australia (Invited Presenter)
1998
Preoperative Diagnosis of Cancer by Magnetic Resonance Spectroscopy
Institute for Magnetic Resonance Research, Australia (Keynote Address)
1999
Preoperative Diagnosis of Cancer by Magnetic Resonance Spectroscopy
Inaugural Magnetic Resonance in Neurosciences Meeting, Australia (Invited Presenter)
2000
Preoperative Diagnosis of Cancer by Magnetic Resonance Spectroscopy
Royal Australasian College of Radiology, Australia (Invited Presenter)
2000
Preoperative Diagnosis of Cancer by Magnetic Resonance Spectroscopy
MRI/MRS Practical Applications, Australia (Keynote Address)
2001
Preoperative Diagnosis of Cancer by Magnetic Resonance Spectroscopy
Medical Imaging Australia Conference, Australia (Invited Presenter)
2001
Preoperative Diagnosis of Cancer by Magnetic Resonance Spectroscopy
Royal Australian and New Zealand College of Radiologists Annual Scientific Meeting, Australia (Invited Presenter)
2001
Preoperative Diagnosis of Cancer by Magnetic Resonance Spectroscopy
Australian and New Zealand Head and Neck Society, Australia (Keynote Address)
2001
Preoperative Diagnosis of Cancer by Magnetic Resonance Spectroscopy
MRI/MRS Practical Applications, Australia (Keynote Address)
2003
Preoperative Diagnosis of Cancer by Magnetic Resonance Spectroscopy
Familial Cancer Symposium, Australia (Invited Presenter)
2003
Preoperative Diagnosis of Cancer by Magnetic Resonance Spectroscopy
Northern Beaches Prostate Cancer Support Group, Australia (Invited Presenter)
2004
Preoperative Diagnosis of Cancer by Magnetic Resonance Spectroscopy
Sydney Breast Clinic, Australia (Invited Presenter)
2004
Preoperative Diagnosis of Cancer by Magnetic Resonance Spectroscopy
Department of Radiology, St Vincent's Hospital Melbourne, Australia (Invited Presenter)
2006
Preoperative Diagnosis of Cancer by Magnetic Resonance Spectroscopy
Refresher Course on Breast MR, RSNA Chicago, United States (Invited Presenter)
2008
Preoperative Diagnosis of Cancer by Magnetic Resonance Spectroscopy
Refresher Course on Breast MR, RSNA Chicago, United States (Invited Presenter)
2009
Preoperative Diagnosis of Cancer by Magnetic Resonance Spectroscopy
Department of Radiology, University of Maryland, United States (Invited Presenter)
2009
Preoperative Diagnosis of Cancer by Magnetic Resonance Spectroscopy
NCI Small Animal Imaging Symposium, Washington, United States (Invited Presenter)
2009
Preoperative Diagnosis of Cancer by Magnetic Resonance Spectroscopy
Refresher Course on Breast MR, RSNA Chicago, United States (Invited Presenter)
2010
Development of MRS as an Adjunct to Hisopathology
Advances in Physiological Chemistry by In Vivo NMR, Boston, United States (Invited Presenter)
1995
Development of MRS as an Adjunct to Hisopathology
5th International Conference on Anticancer Research, Greece (Invited Presenter)
1995
Development of MRS as an Adjunct to Hisopathology
4th Scientific Meeting and Exhibition of the Society of Magnetic Resonance, New York, United States (Invited Presenter)
1996
Development of MRS as an Adjunct to Hisopathology
Liposciences, Raleigh Durham, United States (Invited Presenter)
2004
Spectroscopy on Biopsy and In Vivo
VII Scientific Meeting, International Society for Magnetic Resonance in Medicine, Philadelphia, United States (Keynote Address)
1999
Spectroscopy on Biopsy and In Vivo
XIX International Conference on Magnetic Resonance and Biological Systems, Florence, Italy (Keynote Address)
2000
Spectroscopy on Biopsy and In Vivo
Clinical MR Spectroscopy MRS Training Course, Honolulu, United States (Invited Presenter)
2000
Spectroscopy on Biopsy and In Vivo
RSNA, Chicago, United States (Invited Presenter)
2000
Spectroscopy on Biopsy and In Vivo
8th Scientific Meeting, International Society for MR in Medicine, Denver, United States (Invited Presenter)
2000
Spectroscopy on Biopsy and In Vivo
3rd International Symposium, Japanese Society for MR in Medicine, Tokyo, Japan (Keynote Address)
2001
Spectroscopy on Biopsy and In Vivo
9th Scientific Meeting, International Society for MR in Medicine, Glasgow, United Kingdom (Invited Presenter)
2001
Spectroscopy on Biopsy and In Vivo
MRI/MRS 2001, Cairns, Australia (Invited Presenter)
2001
Spectroscopy on Biopsy and In Vivo
Biennial Conference of the New Zealand & Australian Society for Magnetic Resonance, Taupo, New Zealand (Invited Presenter)
2002
Spectroscopy on Biopsy and In Vivo
XXth International Conference on Magnetic Resonance in Biological Systems, Toronto, Canada (Keynote Address)
2002
Spectroscopy on Biopsy and In Vivo
XIV International Biophysics Congress, Buenos Aires, Argentina (Invited Presenter)
2002
Spectroscopy on Biopsy and In Vivo
3rd International Congres on MR-Mammography, Jena, Germany (Invited Presenter)
2003
Spectroscopy on Biopsy and In Vivo
XIXth International Congress of Biochemistry and Molecular Biology, Toronto, Canada (Keynote Address)
2003
Spectroscopy on Biopsy and In Vivo
Huntington Medical Center, Pasadena, United States (Invited Presenter)
2003
Spectroscopy on Biopsy and In Vivo
12th International Society for Magnetic Resonance in Medicine, Kyoto, Japan (Invited Presenter)
2003
Spectroscopy on Biopsy and In Vivo
4th International congress on MR-Mammography, Jena, Germany (Invited Presenter)
2004
Spectroscopy on Biopsy and In Vivo
MRI/MRS Clinical and Practical Applications, Port Douglas, Australia (Invited Presenter)
2003
Spectroscopy on Biopsy and In Vivo
International Society for Magnetic Resonance in Medicine, Kyoto, Japan (Invited Presenter)
2004
Spectroscopy on Biopsy and In Vivo
Brigham and Women's Hospital, Harvard Medical School, Boston, United States (Invited Presenter)
2004
Spectroscopy on Biopsy and In Vivo
National Research Council Institute for Biodiagnostics, Canada (Invited Presenter)
2004
Spectroscopy on Biopsy and In Vivo
New York University Department of Radiology, New York, United States (Invited Presenter)
2004
Spectroscopy on Biopsy and In Vivo
MRI/MRS Clinical and Practical Applications, Port Douglas, Australia (Invited Presenter)
2005
Spectroscopy on Biopsy and In Vivo
Biomedical MR, New Delhi, India (Keynote Address)
2005
Spectroscopy on Biopsy and In Vivo
International Congress on MR-Mammography, Jena, Germany (Invited Presenter)
2005
Spectroscopy on Biopsy and In Vivo
Molecular Imaging, University of California, San Francisco, United States (Invited Presenter)
2005
Spectroscopy on Biopsy and In Vivo
Department of Molecular Imaging, John Hopkins Hospital, Baltimore, United States (Invited Presenter)
2005
Spectroscopy on Biopsy and In Vivo
International Congress on MR-Mammography, Jena, Germany (Invited Presenter)
2006
Spectroscopy on Biopsy and In Vivo
Department of Radiology, University of Singapore, Singapore (Invited Presenter)
2006
Spectroscopy on Biopsy and In Vivo
Molecular Imaging Congress, Nice, France (Keynote Address)
2009
Spectroscopy on Biopsy and In Vivo
IUPAB International Biophysics Congress, Beijing, China (Invited Presenter)
2011
Immunoglobulin Structure
Royal Society Conversazione, London, United Kingdom (Invited Presenter)
1974
Immunoglobulin Structure
Homogenous Immunoglobulin Workshop, National Institute of Health, Bethesada, United States (Invited Presenter)
1975
Immunoglobulin Structure
Conference on Magnetic Resonance in Medicine, United Kingdom (Invited Presenter)
1982
Development of MRS as an Adjunct to Hisopathology
Magnetic Resonance in Cancer, Canada (Keynote Address)
1985
Development of MRS as an Adjunct to Hisopathology
Society of Magnetic Resonance in Medicine, Montreal, Canada (Invited Presenter)
1986
Development of MRS as an Adjunct to Hisopathology
International Cancer Congress, Hungary (Invited Presenter)
1986
Development of MRS as an Adjunct to Hisopathology
International Conference on Magnetic Resonance in Biological Systems, Germany (Invited Presenter)
1986
Development of MRS as an Adjunct to Hisopathology
Magnetic Resonance in Medicine, New York, United States (Invited Presenter)
1987
Development of MRS as an Adjunct to Hisopathology
EEC Concerted Research Project on Tissue Characterisation by MRS and MRI, France (Invited Presenter)
1989
Development of MRS as an Adjunct to Hisopathology
In Vivo NMR Spectroscopy, Germany (Invited Presenter)
1989
Development of MRS as an Adjunct to Hisopathology
Special Topics in Magnetic Resonance, Canada (Invited Presenter)
1990
Development of MRS as an Adjunct to Hisopathology
Gray conference on Tumor Assessment in Response to Therapy, United Kingdom (Invited Presenter)
1992
Development of MRS as an Adjunct to Hisopathology
An Insight from NMR, University of British Columbia, Canada (Invited Presenter)
1993
Development of MRS as an Adjunct to Hisopathology
Society of Magnetic Resonance in Medicine, United States (Invited Presenter)
1993
Development of MRS as an Adjunct to Hisopathology
Society of Magnetic Resonance in Medicine, United States (Invited Presenter)
1994
Development of MRS as an Adjunct to Hisopathology
ISMRM Mini-Categorical Course - Cancer Detection, United States (Invited Presenter)
1994
Spectroscopy of the Breast on Biopsy
MR Breast Cancer Conference, Society of Magnetic Resonance, United States (Invited Presenter)
1995
Spectroscopy of the Breast on Biopsy
US Department of Defense, United States (Invited Presenter)
1998
Spectroscopy of the Breast on Biopsy
US Department of Defense, United States (Invited Presenter)
2002
Neurospectroscopy to Monitor Pain, Head Injury and PTSD
United States Congress, United States (Invited Presenter)
2010
Neurospectroscopy to Monitor Pain, Head Injury and PTSD
Australian Defence Force, Australia (Invited Presenter)
2012
Neurospectroscopy to Monitor Pain, Head Injury and PTSD
CTTSO, United States (Invited Presenter)
2012
Neurospectroscopy to Monitor Pain, Head Injury and PTSD
Australian Army Colonels, Australia (Invited Presenter)
2013

Collaboration

Professor Mountford Mountford has led and has participated in research in different areas of human disease. These activities include cancer diagnosis and prognosis, neuro-degenerative diseases such as those associated with chronic pain and brain injury and more recently metabolic syndrome and obesity. All aspects of this research are multidisciplinary. The results of this research have been reported in a variety of peer-reviewed journal articles. She is the author and co-author of more than 160 peer-reviewed articles and four patents.

Current collaborations trough her position at the University of Newcastle, Australia, include with the Priority Research Centre for Cancer and the Hunter Medical Research Institute's Cancer program.

As Director, Center for Clinical Spectroscopy at the Brigham and Woman's Hospital in Boston, MA, she leads the application of advanced spectroscopy methods and the scientific evaluation of spectroscopy technology for other groups within the Partners organization and around the world. The Center works closely with clinical collaborators as well as with other groups within the Hospital and Harvard Medical School.

Various research projects are supported by federal and private grants, and there is extensive collaboration with multiple industrial partners. There are long standing collaborations in place with the Institute for Biodiagnostics at the National Research Council of Canada and more recently with the Draper Laboratories.

The Center also offers a variety of training opportunities for fellows, junior scientists and clinical specialists to advance the field of MR spectroscopy through the active dissemination of new MRS technology.

Administrative

Administrative expertise

2007 - Present | Director of Clinical Spectroscopy, Department of Radiology, Brigham and Women's Hospital, Boston, MA, U.S.A.

1998 - 2006 | Foundation Head, Department of Magnetic Resonance in Medicine, University of Sydney, NSW, Australia

1995 - 2006 | Foundation Chief Executive, Institute for Magnetic Resonance Research, Royal North Shore Hospital, St Leonard's, NSW, Australia

Teaching

Teaching keywords

  • Radiology

Teaching expertise

Professor Mountford has previously held academic positions at Oxford University, UK, the University of Sydney, Australia and Harvard Medical School, Boston, USA.

Edit

Publications

For publications that are currently unpublished or in-press, details are shown in italics.

Click on a category title below to expand the list of citations for that specific category.

Journal article (98 outputs)

YearCitationAltmetricsLink
2011Ramadan S, Andronesi OC, Stanwell PT, Lin AP, Sorensen AG, Mountford CE, 'Use of in vivo two-dimensional mr spectroscopy to compare the biochemistry of the human brain to that of glioblastoma', Radiology, 259 540-549 (2011) [C1]
2011Ramadan S, Mountford C, 'Adiabatic Localized Correlation Spectroscopy (AL-COSY) - Application in Muscle and Brain', Journal of Magnetic Resonance Imaging, 33 1447-1455 (2011) [C1]

Co-authors: Saadallah Ramadan

2011Cocuzzo D, Lin A, Ramadan S, Mountford C, Keshava N, 'Algorithms for characterizing brain metabolites in two-dimensional in vivo MR correlation spectroscopy', Proceedings of the Annual International Conference of the IEEE Engineering in Medicine and Biology Society, EMBS, 4929-4934 (2011)
2010Stanwell PT, Siddall P, Keshava N, Cocuzzo D, Ramadan S, Lin A, et al., 'Neuro magnetic resonance spectroscopy using wavelet decomposition and statistical testing identifies biochemical changes in people with spinal cord injury and pain', Neuroimage, 53 544-552 (2010) [C1]
2010Ramadan S, Ratai EM, Wald LL, Mountford CE, 'IN VIVO 1D and 2D Correlation MR Spectroscopy of the Soleus Muscle at 7T', Journal of Magnetic Resonance, 204 91-98 (2010) [C1]

Co-authors: Saadallah Ramadan

2010Woodhams R, Kakita S, Hata H, Iwabuchi K, Kuranami M, Gautam S, et al., 'Identification of residual breast carcinoma following neoadjuvant chemotherapy: Diffusion-weighted imaging - Comparison with contrast-enhanced MR imaging and pathologic findings', Radiology, 254 357-366 (2010) [C1]
2010Andronesi OC, Ramadan S, Ratai EM, Jennings D, Mountford CE, Sorensen GA, 'Spectroscopic imaging with improved gradient modulated constant adiabaticity pulses on high-field clinical scanners', Journal of Magnetic Resonance, 203 283-293 (2010) [C1]

Co-authors: Saadallah Ramadan

2010Andronesi OC, Ramadan S, Mountford CE, Sorensen AG, 'Low-Power Adiabatic Sequences for In Vivo Localized Two-Dimensional Chemical Shift Correlated MR Spectroscopy', MAGNETIC RESONANCE IN MEDICINE, 64 1542-1556 (2010) [C1]
2010Birdwell RL, Mountford CE, Iglehart JD, 'Molecular Imaging of the Breast', RADIOLOGIC CLINICS OF NORTH AMERICA, 48 1075-+ (2010) [C1]
2010Mountford CE, Stanwell PT, Lin A, Ramadan S, Ross B, 'Neurospectroscopy: The past, present and future', Chemical Reviews, 110 3060-3086 (2010)
2009Birdwell RL, Mountford CE, Iglehart JD, 'Molecular Imaging of the Breast', AMERICAN JOURNAL OF ROENTGENOLOGY, 193 367-376 (2009) [C1]
2009Mountford CE, Ramadan SA, Stanwell PT, Malycha PL, 'Proton MRS of the Breast in the clinical setting.', NMR in Biomedicine, 22 54-64 (2009) [C1]
2009Tokuda J, Schmitt M, Sun Y, Patz S, Tang Y, Mountford CE, et al., 'Lung Motion and Volume Measurement by Dynamic 3D MRI Using a 128-Channel Receiver Coil', ACADEMIC RADIOLOGY, 16 22-27 (2009) [C1]
2009Woodhams R, Kakita S, Hata H, Iwabuchi K, Umeoka S, Mountford CE, Hatabu H, 'Diffusion-Weighted Imaging of Mucinous Carcinoma of the Breast: Evaluation of Apparent Diffusion Coefficient and Signal Intensity in Correlation With Histologic Findings', AMERICAN JOURNAL OF ROENTGENOLOGY, 193 260-266 (2009) [C1]
2009Ramadan S, Mountford C, 'Two-Dimensional Magnetic Resonance Spectroscopy in Biopsy and In Vivo 161-199 (2009)

Co-authors: Saadallah Ramadan

2008Mountford CE, Stanwell PT, Ramadan S, 'Breast MR imaging at 3.0 T', Radiology, 248 319-320 (2008) [C1]
2008Swindle P, Ramadan S, Stanwell PT, McCredie S, Russell P, Mountford C, 'Proton magnetic resonance spectroscopy of the central, transition and peripheral zones of the prostate: Assignments and correlation with histopathology.', Magnetic Resonance Materials in Physics Biology and Medicine, 21 423-434 (2008) [C1]
2008Stanwell PT, Russell P, Carter J, Pather S, Heintze S, Mountford C, 'Evaluation of ovarian tumors by proton magnetic resonance spectroscopy at three tesla', Investigative Radiology, 43 745-751 (2008) [C1]
2008Mountford C, 'Magnetic resonance imaging and spectroscopy of the prostate', Magnetic Resonance Materials in Physics, Biology and Medicine, 21 369-370 (2008) [C3]
2007Stanwell PT, Mountford C, 'In vivo proton MR spectroscopy of the breast', Radiographics, 27 253-266 (2007) [C1]
2007Ramadan S, Thomas MA, Mountford CE, 'Phase-rotated MR spectroscopy using dual-PRESS: theory and application in human brain', DATA MINING, SYSTEMS ANALYSIS, AND OPTIMIZATION IN BIOMEDICINE, 953 277-291 (2007)
2006Siddall PJ, Stanwell PT, Woodhouse A, Somorjai RL, Dolenko B, Nikulin A, et al., 'Magnetic resonance spectroscopy detects biochemical changes in the brain associated with chronic low back pain: A preliminary report', Anesthesia and Analgesia, 102 1164-1168 (2006) [C1]
2006Mountford C, Lean C, Malycha P, Russell P, 'Proton spectroscopy provides accurate pathology on biopsy and in vivo', Journal of Magnetic Resonance Imaging, 24 459-477 (2006)
2005Bourne RM, Stanwell PT, Stretch JR, Scolyer RA, Thompson JF, Mountford CE, Lean CL, 'In vivo and ex vivo proton MR spectroscopy of primary and secondary melanoma', European Journal of Radiology, 53 506-513 (2005) [C1]
2005Stanwell PT, Gluch L, Clark D, Tomanek B, Baker L, Giuffre B, et al., 'Specificity of choline metabolites for in vivo diagnosis of breast cancer using 1H MRS at 1.5 T', European Radiology, 15 1037-1043 (2005) [C1]
2005Mountford C, Stanwell PT, Ferrier A, Bourne R, Doran S, Christie J, et al., 'In vivo spectroscopy and imaging of the ovary in vivo at 3 tesla and spectroscopy on biopsy at 8.5 tesla', Journal of Women's Imaging, 7 71-76 (2005) [C1]
2005Dzendrowskyj TE, Dolenko B, Sorrell TC, Somorjai RL, Malik R, Mountford CE, Himmelreich U, 'Diagnosis of cerebral cryptococcoma using a computerized analysis of 1H NMR spectra in an animal model', Diagnostic Microbiology and Infectious Disease, 52 101-105 (2005)
2005Stretch J, Thompson J, Scolyer R, Mountford C, Lean C, 'Magnetic resonance spectroscopy in the management of melanoma', Cancer Forum, 29 73-76 (2005)
2005Himmelreich U, Accurso R, Malik R, Dolenko B, Somorjai RL, Gupta RK, et al., 'Identification of Staphylococcus aureus brain abscesses: Rat and human studies with1H MR spectroscopy', Radiology, 236 261-270 (2005)
2005Stretch JR, Somorjai R, Bourne R, Hsiao E, Scolyer RA, Dolenko B, et al., 'Melanoma metastases in regional lymph nodes are accurately detected by proton magnetic resonance spectroscopy of fine-needle aspirate biopsy samples', ANNALS OF SURGICAL ONCOLOGY, 12 943-949 (2005)
2004Mountford CE, Doran S, Lean CL, Russell P, 'Proton MRS can determine the pathology of human cancers with a high level of accuracy', Chemical Reviews, 104 3677-3704 (2004)
2004Baumgartner R, Somorjai R, Bowman C, Sorrell TC, Mountford CE, Himmelreich U, 'Unsupervised feature dimension reduction for classification of MR spectra', Magnetic Resonance Imaging, 22 251-256 (2004)
2004Lean C, Doran S, Somorjai RL, Malycha P, Clarke D, Himmelreich U, et al., 'Determination of grade and receptor status from the primary breast lesion by magnetic resonance spectroscopy', Technology in Cancer Research and Treatment, 3 551-556 (2004)
2004Laveissière G, Todor L, Degrande N, Jaminion S, Jutier C, di Salvo R, et al., 'Measurement of the generalized polarizabilities of the proton in virtual compton scattering at Q2 = 0.92 and 1.76 GeV2 ', Physical Review Letters, 93 (2004)
2004Laveissière G, Degrande N, Jaminion S, Jutier C, Todor L, Di Salvo R, et al., 'Backward electroproduction of p0 mesons on protons in the region of nucleon resonances at four momentum transfer squared Q2=1.0 GeV2 ', Physical Review C - Nuclear Physics, 69 (2004)
2003Bourne R, Katelaris P, Danieletto S, Dzendrowskyj T, Stanwell PT, Mountford C, 'Detection of prostate cancer by magnetic resonance imaging and spectroscopy in vivo', ANZ Journal of Surgery, 73 666-668 (2003) [C1]
2003Himmelreich U, Allen C, Dowd S, Malik R, Shehan BP, Mountford C, Sorrell TC, 'Identification of metabolites of importance in the pathogenesis of pulmonary cryptococcoma using nuclear magnetic resonance spectroscopy', Microbes and Infection, 5 285-290 (2003)
2003Himmelreich U, Somorjai RL, Dolenko B, Lee OC, Daniel H-M, Murray R, et al., 'Rapid identification of Candida species by using nuclear magnetic resonance spectroscopy and a statistical classification strategy', Applied and Environmental Microbiology, 69 4566-4574 (2003)
2003Doran ST, Falk GL, Somorjai RL, Lean CL, Himmelreich U, Philips J, et al., 'Pathology of Barrett's esophagus by proton magnetic resonance spectroscopy and a statistical classification strategy', American Journal of Surgery, 185 232-238 (2003)
2003Bourne R, Dzendrowskyj T, Mountford C, 'Leakage of metabolites from tissue biopsies can result in large errors in quantitation by MRS', NMR in Biomedicine, 16 96-101 (2003)
2003Lean CL, Bourne R, Thompson JF, Scolyer RA, Stretch J, Li L-XL, et al., 'Rapid detection of metastatic melanoma in lymph nodes using proton magnetic resonance spectroscopy of fine needle aspiration biopsy specimens', Melanoma Research, 13 259-261 (2003)
2002Soper R, Himmelreich U, Painter D, Somorjai RL, Lean CL, Dolenko B, et al., 'Pathology of hepatocellular carcinoma and its precursors using proton magnetic resonance spectroscopy and a statistical classification strategy', PATHOLOGY, 34 417-422 (2002)
2001Mountford CE, Somorjai RL, Malycha P, Gluch L, Lean C, Russell P, et al., 'Diagnosis and prognosis of breast cancer by magnetic resonance spectroscopy of fine-needle aspirates analysed using a statistical classification strategy', British Journal of Surgery, 88 1234-1240 (2001)
2001Bourne R, Himmelreich U, Sharma A, Mountford C, Sorrell T, 'Identification of Enterococcus, Streptococcus, and Staphylococcus by multivariate analysis of proton magnetic resonance spectroscopic data from plate cultures', Journal of Clinical Microbiology, 39 2916-2923 (2001)
2001Himmelreich U, Dzendrowskyj TE, Allen C, Dowd S, Malik R, Shehan BP, et al., 'Cryptococcomas distinguished from gliomas with MR spectroscopy: an experimental rat and cell culture study.', Radiology, 220 122-128 (2001)
1998Malycha P, Mountford C, 'Magnetic resonance spectroscopy and breast cancer', Australian and New Zealand Journal of Surgery, 68 859-862 (1998)
1997Mackinnon WB, Barry PA, Malycha PL, Gillett DJ, Russell P, Lean CL, et al., 'Fine-needle biopsy specimens of benign breast lesions distinguished from invasive cancer ex vivo with proton MR spectroscopy', Radiology, 204 661-666 (1997)
1997Mountford CE, Doran S, Lean CL, Russell P, 'Cancer pathology in the year 2000', Biophysical Chemistry, 68 127-135 (1997)
1996Ende D, Rutter A, Russell P, Mountford CE, 'Chemical shift imaging of human colorectal tissue (Ex vivo)', NMR in Biomedicine, 9 179-183 (1996)
1996Rutter A, Kunnecke B, Dowd S, Russell P, Delbridge L, Mountford CE, 'Proton magnetic resonance and human thyroid neoplasia .3. Ex vivo chemical-shift microimaging', JOURNAL OF MAGNETIC RESONANCE SERIES B, 110 240-248 (1996)
1996Rutter A, Mackinnon WB, Huschtscha LI, Mountford CE, 'A proton magnetic resonance spectroscopy study of aging and transformed human fibroblasts', Experimental Gerontology, 31 669-686 (1996)
1996Delikatny EJ, Roman SK, Hancock R, Jeitner TM, Lander CM, Rideout DC, Mountford CE, 'Tetraphenylphosphonium chloride induced MR-visible lipid accumulation in a malignant human breast cell line', International Journal of Cancer, 67 72-79 (1996)
1996Mackinnon WB, Delbridge L, Russell P, Lean CL, May GL, Doran S, et al., 'Two-dimensional proton magnetic resonance spectroscopy for tissue characterization of thyroid neoplasms', WORLD JOURNAL OF SURGERY, 20 841-847 (1996)
1996Delikatny EJ, Lander CM, Jeitner TM, Hancock R, Mountford CE, 'Modulation of MR-visible mobile lipid levels by cell culture conditions and correlations with chemotactic response', International Journal of Cancer, 65 238-245 (1996)
1995MACKINNON WB, RUSSELL P, MAY GL, MOUNTFORD CE, 'CHARACTERIZATION OF HUMAN OVARIAN EPITHELIAL TUMORS (EX-VIVO) BY PROTON MAGNETIC-RESONANCE SPECTROSCOPY', INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 5 211-221 (1995)
1995LEAN CL, DELBRIDGE L, RUSSELL P, MAY GL, MACKINNON WB, ROMAN S, et al., 'DIAGNOSIS OF FOLLICULAR THYROID LESIONS BY PROTON MAGNETIC-RESONANCE ON FINE-NEEDLE BIOPSY', JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 80 1306-1311 (1995)
1995SOMORJAI RL, NIKULIN AE, PIZZI N, JACKSON D, SCARTH G, DOLENKO B, et al., 'COMPUTERIZED CONSENSUS DIAGNOSIS - A CLASSIFICATION STRATEGY FOR THE ROBUST ANALYSIS OF MR SPECTRA .1. APPLICATION TO H-1 SPECTRA OF THYROID NEOPLASMS', MAGNETIC RESONANCE IN MEDICINE, 33 257-263 (1995)
1994Mackinnon WB, Huschtscha L, Dent K, Hancock R, Paraskeva C, Mountford CE, 'Correlation of cellular differentiation in human colorectal carcinoma and adenoma cells lines with metabolite profiles determined by 1H magnetic resonance spectroscopy', International Journal of Cancer, 59 248-261 (1994)
1994Mountford CE, Mackinnon WB, 'Proton magnetic resonance spectroscopy of lymphocytes: An historical perspective', ImmunoMethods, 4 98-112 (1994)
1994RUSSELL P, LEAN CL, DELBRIDGE L, MAY GL, DOWD S, MOUNTFORD CE, 'PROTON MAGNETIC-RESONANCE AND HUMAN THYROID NEOPLASIA .1. DISCRIMINATION BETWEEN BENIGN AND MALIGNANT NEOPLASMS', AMERICAN JOURNAL OF MEDICINE, 96 383-388 (1994)
1994KUNNECKE B, DELIKATNY EJ, RUSSELL P, HUNTER JC, MOUNTFORD CE, 'PROTON MAGNETIC-RESONANCE AND HUMAN CERVICAL NEOPLASIA .2. EX-VIVO CHEMICAL-SHIFT MICROIMAGING', JOURNAL OF MAGNETIC RESONANCE SERIES B, 104 135-142 (1994)
1993DELIKATNY EJ, RUSSELL P, HUNTER JC, HANCOCK R, ATKINSON KH, VANHAAFTENDAY C, MOUNTFORD CE, 'PROTON MR AND HUMAN CERVICAL NEOPLASIA - EX-VIVO SPECTROSCOPY ALLOWS DISTINCTION OF INVASIVE-CARCINOMA OF THE CERVIX FROM CARCINOMA IN-SITU AND OTHER PREINVASIVE LESIONS', RADIOLOGY, 188 791-796 (1993)
1993Mountford CE, Lean CL, Mackinnon WB, Russell P, 'The Use of Proton MR in Cancer Pathology', Annual Reports on NMR Spectroscopy, 27 173-215 (1993)
1993MACKINNON WB, DYNE M, HANCOCK R, GRANT AJ, RUSSELL P, MOUNTFORD CE, 'MALIGNANCY-RELATED CHARACTERISTICS OF WILD-TYPE AND DRUG-RESISTANT CHINESE-HAMSTER OVARY CELLS', PATHOLOGY, 25 268-276 (1993)
1993Lean CL, Newland RC, Ende DA, Bokey EL, Smith ICP, Mountford CE, 'Assessment of human colorectal biopsies by 1H MRS: Correlation with histopathology', Magnetic Resonance in Medicine, 30 525-533 (1993)
1993MOUNTFORD CE, LEAN CL, HANCOCK R, DOWD S, MACKINNON WB, TATTERSALL MHN, RUSSELL P, 'MAGNETIC-RESONANCE SPECTROSCOPY DETECTS CANCER IN DRAINING LYMPH-NODES', INVASION & METASTASIS, 13 57-71 (1993)
1992MACKINNON WB, HANCOCK R, DYNE M, RUSSELL P, MOUNTFORD CE, 'EVALUATION OF AN INVITRO INVASION ASSAY FOR USE ON SOLID TISSUE SAMPLES AND CULTURED-CELLS', INVASION & METASTASIS, 12 241-252 (1992)
1992Mackinnon WB, May GL, Mountford CE, 'Esterified cholesterol and triglyceride are present in plasma membranes of Chinese hamster ovary cells', European Journal of Biochemistry, 205 827-839 (1992)
1992Lean CL, Mackinnon WB, Delikatny EJ, Whitehead RH, Mountford CE, 'Cell-surface fucosylation and magnetic resonance spectroscopy characterization of human malignant colorectal cells', Biochemistry, 31 11095-11105 (1992)
1991WRIGHT LC, MAY GL, MACKINNON WB, GREGORY P, HOLMES KT, DYNE M, et al., 'TUMOR EVOLUTION IN RATS MONITORED BY CHANGES TO SERUM AND LIPOPROTEINS', INVASION & METASTASIS, 11 332-347 (1991)
1991Lean CL, Mackinnon WB, Mountford CE, 'Fucose in 1H COSY spectra of plasma membrane fragments shed from human malignant colorectal cells', Magnetic Resonance in Medicine, 20 306-311 (1991)
1991Holmes KT, Mountford CE, 'Identification of triglyceride in malignant cells', Journal of Magnetic Resonance (1969), 93 407-409 (1991)
1991Delikatny EJ, Hull WE, Mountford CE, 'The effect of altering time domains and window functions in two-dimensional proton COSY spectra of biological specimens', Journal of Magnetic Resonance (1969), 94 563-573 (1991)
1990MOUNTFORD CE, DELIKATNY EJ, DYNE M, HOLMES KT, MACKINNON WB, FORD R, et al., 'UTERINE CERVICAL PUNCH BIOPSY SPECIMENS CAN BE ANALYZED BY H-1 MRS', MAGNETIC RESONANCE IN MEDICINE, 13 324-331 (1990)
1989Mackinnon WB, Dyne M, Holmes KT, Mountford CE, Gupta RS, 'Further evidence that the narrow 1H magnetic resonance signals from malignant cells do not arise from intracellular lipid droplets.', NMR in biomedicine, 2 161-164 (1989)
1989WRIGHT LC, SULLIVAN DR, MULLER M, DYNE M, TATTERSALL MHN, MOUNTFORD CE, 'ELEVATED APOLIPOPROTEIN(A) LEVELS IN CANCER-PATIENTS', INTERNATIONAL JOURNAL OF CANCER, 43 241-244 (1989)
1989Holmes KT, Dyne M, Williams PG, May GL, Tripp E, Wright LC, Mountford CE, 'Vinblastine sensitivity of leukaemic lymphoblasts modulated by serum lipid', FEBS Letters, 244 103-107 (1989)
1988Holmes KT, Mackinnon WB, May GL, Wright LC, Dyne M, Tattersall MH, et al., 'Hyperlipidemia as a biochemical basis of magnetic resonance plasma test for cancer.', NMR in biomedicine, 1 44-49 (1988)
1988Williams PG, Saunders JK, Dyne M, Mountford CE, Holmes KT, 'Application of a T2-filtered COSY experiment to identify the origin of slowly relaxing species in normal and malignant tissue', Magnetic Resonance in Medicine, 7 463-471 (1988)
1988Wright LC, May GL, Gregory P, Dyne M, Holmes KT, Williams PG, Mountford CE, 'Inhibition of metastatic potential by fucosidase: An NMR study identifies a cell surface metastasis marker', Journal of Cellular Biochemistry, 37 49-59 (1988)
1988Mountford CE, Wright LC, 'Organization of lipids in the plasma membranes of malignant and stimulated cells: a new model', Trends in Biochemical Sciences, 13 172-177 (1988)
1988Mackinnon WB, Mountford CE, 'Assessment of enzyme inhibition or stimulation in plasma membrane preparations', Analytical Biochemistry, 175 386-389 (1988)
1987MOUNTFORD CE, WRIGHT LC, DYNE M, MAY GL, MACKINNON WB, HOLMES KT, et al., 'PROTEOLIPID IDENTIFIED BY MAGNETIC-RESONANCE SPECTROSCOPY IN PLASMA OF A PATIENT WITH BORDERLINE OVARIAN TUMOR', LANCET, 1 829-834 (1987)
1987MOUNTFORD CE, TATTERSALL MHN, 'PROTON MAGNETIC-RESONANCE SPECTROSCOPY AND TUMOR-DETECTION', CANCER SURVEYS, 6 285-314 (1987)
1987Holmes KT, Williams PG, King NJC, May GL, Dyne M, Bloom M, Mountford CE, 'A comparison of the chemical analyses of cell lipids with their complete proton NMR spectrum', Magnetic Resonance in Medicine, 4 567-574 (1987)
1986May GL, Wright LC, Holmes KT, Williams PG, Smith IC, Fox RM, Mountford CE, 'Assignment of methylene proton resonances in NMR spectra of embryonic and transformed cells to plasma membrane triglyceride', Journal of Biological Chemistry, 261 3048-3053 (1986)
1986Bloom M, Holmes KT, Mountford CE, Williams PG, 'Complete proton magnetic resonance in whole cells', Journal of Magnetic Resonance (1969), 69 73-91 (1986)
1986Wright LC, Dyne M, Holmes KT, Romeo T, Mountford CE, 'Cellular resistance to vinblastine is associated with altered respiratory function', Biochemistry International, 13 295-305 (1986)
1986Wright LC, May GL, Dyne M, Mountford CE, 'A proteolipid in cancer cells is the origin of their high-resolution NMR spectrum', FEBS Letters, 203 164-168 (1986)
1986Holmes KT, Williams PG, May GL, Gregory P, Wright LC, Dyne M, Mountford CE, 'Cell surface involvement in cancer metastasis: an NMR study', FEBS Letters, 202 122-126 (1986)
1986MOUNTFORD CE, MAY GL, WILLIAMS PG, TATTERSALL MHN, RUSSELL P, SAUNDERS JK, et al., 'CLASSIFICATION OF HUMAN-TUMORS BY HIGH-RESOLUTION MAGNETIC-RESONANCE SPECTROSCOPY', LANCET, 1 651-653 (1986)
1985Wright LC, Dyne M, Holmes KT, Mountford CE, 'Phospholipid and ether linked phospholipid content alter with cellular resistance to vinblastine', Biochemical and Biophysical Research Communications, 133 539-545 (1985)
1985Williams PG, Helmer MA, Wright LC, Dyne M, Fox RM, Holmes KT, et al., 'Lipid domain in cancer cell plasma membrane shown by 1H NMR to be similar to a lipoprotein', FEBS Letters, 192 159-164 (1985)
1984Cross KJ, Holmes KT, Mountford CE, Wright PE, 'Assignment of acyl chain resonances from membranes of mammalian cells by two-dimensional NMR methods', Biochemistry, 23 5895-5897 (1984)
1984Mountford CE, Mackinnon WB, Bloom M, Elliott Burnell E, Smith ICP, 'NMR methods for characterizing the state of the surfaces of complex mammalian cells', Journal of Biochemical and Biophysical Methods, 9 323-330 (1984)
1984Mountford CE, Wright LC, Holmes KT, Mackinnon WB, Gregory P, Fox RM, 'High-resolution proton nuclear magnetic resonance analysis of metastatic cancer cells', Science, 226 1415-1418 (1984)
1982Mountford CE, Grossman G, Holmes KT, O'Sullivan WJ, Hampson AW, Raison RL, Webster R, 'Effect of monoclonal anti-neuraminidase antibodies on the kinetic behaviour of influenza virus neuraminidase', Molecular Immunology, 19 811-816 (1982)
1981Mountford CE, Grossman G, Holmes KT, Hampson AW, Reid GH, 'Interaction of influenza virus with chicken fibroblasts: A proton magnetic resonance study', Biochemical and Biophysical Research Communications, 100 1183-1188 (1981)
Show 95 more

Conference (4 outputs)

YearCitationAltmetricsLink
2013Stanwell PT, Carter J, Russell P, Mountford CE, 'Multiparametric approach to diagnose ovarian lesions preoperatively: Combination of ADC and MRS', Proceedings of the International Society for Magnetic Resonance in Medicine, Salt Lake City, Utah (2013) [E3]

Co-authors: Peter Stanwell

2012Ramadan S, Baltzer PAT, Lin A, Stanwell PT, Box H, Kaiser WA, Mountford CE, 'L-COSY of breast cancer at 3T', European Journal of Radiology, Jena, Germany (2012) [E1]
2012Mountford CE, Schuster C, Baltzer PAT, Malycha P, Kaiser WA, 'MR spectroscopy in the breast clinic is improving', European Journal of Radiology, Jena, Germany (2012) [E3]
1994DELBRIDGE L, LEAN CL, RUSSEL P, MAY GL, ROMAN S, DOWD S, et al., 'PROTON MAGNETIC-RESONANCE AND HUMAN THYROID NEOPLASIA-II - POTENTIAL AVOIDANCE OF SURGERY FOR BENIGN FOLLICULAR NEOPLASMS', WORLD JOURNAL OF SURGERY, HONG KONG, HONG KONG (1994)
Show 1 more
Edit

Grants and Funding

Summary

Number of grants27
Total funding$3,464,104

- Indicates that the researcher may be seeking students for this project.

Click on a grant title below to expand the full details for that specific grant.

2014 (1 grants)

Neurochemical dysfunction following concussion and mild traumatic brain injury in 10-16 year olds $10,000
Funding Body: University of Newcastle

Project Team
Professor Carolyn Mountford, Professor Zsolt Balogh, Doctor Saadallah Ramadan
SchemeRole
Near Miss GrantChief Investigator
Total AmountFunding StartFunding Finish
$10,00020142014
GNo:G1301397

2013 (2 grants)

Travel for discussions in Erlangen.$5,028
Funding Body: Siemens Ltd

Project Team
Professor Carolyn Mountford
SchemeRole
Travel GrantChief Investigator
Total AmountFunding StartFunding Finish
$5,02820132013
GNo:G1300385

ANZMAG 2013 / Asia-Pacific NMR, Brisbane Australia, 27-31 October 2013$925
Funding Body: University of Newcastle - Faculty of Health and Medicine

Project Team
Professor Carolyn Mountford
SchemeRole
Travel GrantChief Investigator
Total AmountFunding StartFunding Finish
$92520132013
GNo:G1301094

2012 (2 grants)

Biochemical origin and potential management of chronic pain$12,000
Funding Body: Foundation Diane

Project Team
Professor Carolyn Mountford, Dr Edward Vickers
SchemeRole
Research DonationChief Investigator
Total AmountFunding StartFunding Finish
$12,00020122013
GNo:G1200452

ISMRM 20th Annual Meeting and Exhibition, Melbourne, 5 - 11 May 2012$1,385
Funding Body: University of Newcastle - Faculty of Health and Medicine

Project Team
Professor Carolyn Mountford
SchemeRole
Travel GrantChief Investigator
Total AmountFunding StartFunding Finish
$1,38520122012
GNo:G1200599

2011 (1 grants)

The 17th International biophysics Congress (IUPAB), Beijing China, 30/10/2011 - 3/11/2011$1,500
Funding Body: University of Newcastle - Faculty of Health and Medicine

Project Team
Professor Carolyn Mountford
SchemeRole
Travel GrantChief Investigator
Total AmountFunding StartFunding Finish
$1,50020112011
GNo:G1100871

1996 (1 grants)

NHMRC$120,000
Funding Body: NHMRC (National Health & Medical Research Council)

SchemeRole
Project GrantChief Investigator
Total AmountFunding StartFunding Finish
$120,00019961996
GNo:185145072

1995 (2 grants)

US Army Program$1,172,740
Funding Body: US Amry Breast Cancer Research Program

SchemeRole
US ArmyChief Investigator
Total AmountFunding StartFunding Finish
$1,172,74019951998
GNo:185002020

MRS Breast Cancer$267,000
Funding Body: NHMRC (National Health & Medical Research Council)

SchemeRole
Project GrantInvestigator
Total AmountFunding StartFunding Finish
$267,00019951997
GNo:185002012

1994 (2 grants)

MR Microimaging$120,000
Funding Body: NHMRC (National Health & Medical Research Council)

SchemeRole
Enabling Grants - Special FacilitiesChief Investigator
Total AmountFunding StartFunding Finish
$120,00019941994
GNo:185001972

Equipment$15,911
Funding Body: University of Sydney

SchemeRole
USyd Research Grant SchemeInvestigator
Total AmountFunding StartFunding Finish
$15,91119941984
GNo:185002004

1993 (3 grants)

Leo and Jenny Foundation$35,000
Funding Body: Leo and Jenny Foundation

SchemeRole
ExternalChief Investigator
Total AmountFunding StartFunding Finish
$35,00019931993
GNo:185001952

Ramaciotti$15,000
Funding Body: Ramaciotti Foundations

SchemeRole
Major Equipment AwardChief Investigator
Total AmountFunding StartFunding Finish
$15,00019931993
GNo:185001964

MRS technology development$9,900
Funding Body: Australian Kidney Foundation

SchemeRole
EquipmentChief Investigator
Total AmountFunding StartFunding Finish
$9,90019931993
GNo:184680943

1992 (3 grants)

MR applied to cancer cells$189,000
Funding Body: NHMRC (National Health & Medical Research Council)

SchemeRole
Project GrantChief Investigator
Total AmountFunding StartFunding Finish
$189,00019921992
GNo:184580018

Leo and Jenny Foundation$20,000
Funding Body: Leo and Jenny Foundation

SchemeRole
ExternalChief Investigator
Total AmountFunding StartFunding Finish
$20,00019921992
GNo:184580034

MR applied to cancer cells$11,000
Funding Body: NHMRC (National Health & Medical Research Council)

SchemeRole
Project GrantChief Investigator
Total AmountFunding StartFunding Finish
$11,00019921992
GNo:184580026

1991 (1 grants)

MRS technology development$18,000
Funding Body: University of Sydney

SchemeRole
SharedChief Investigator
Total AmountFunding StartFunding Finish
$18,00019911991
GNo:184580010

1990 (1 grants)

National Institutes of Health$510,000
Funding Body: National Institutes of Health USA

SchemeRole
National Institutes of Health USAChief Investigator
Total AmountFunding StartFunding Finish
$510,00019901990
GNo:184407465

1989 (2 grants)

NHMRC$110,000
Funding Body: NHMRC (National Health & Medical Research Council)

SchemeRole
Project GrantInvestigator
Total AmountFunding StartFunding Finish
$110,00019891989
GNo:184407453

MRS technology development$76,000
Funding Body: University of Sydney

SchemeRole
SharedChief Investigator
Total AmountFunding StartFunding Finish
$76,00019891989
GNo:184407445

1988 (3 grants)

MRS applied to malignant cells$50,000
Funding Body: Ramaciotti Foundations

SchemeRole
Research GrantChief Investigator
Total AmountFunding StartFunding Finish
$50,00019881988
GNo:184407389

MRS technology development$35,000
Funding Body: University of Sydney

SchemeRole
SharedInvestigator
Total AmountFunding StartFunding Finish
$35,00019881988
GNo:184407409

Ovarian cultured cells studied by MRS$24,926
Funding Body: Private Donation

SchemeRole
Private donationChief Investigator
Total AmountFunding StartFunding Finish
$24,92619881988
GNo:184407397

1984 (3 grants)

Diagnosis of Thyroid Disease$315,000
Funding Body: Cancer Council NSW

SchemeRole
Cancer Council fundingChief Investigator
Total AmountFunding StartFunding Finish
$315,00019841984
GNo:185001996

MRS Kidney$213,789
Funding Body: NHMRC (National Health & Medical Research Council)

SchemeRole
Project GrantInvestigator
Total AmountFunding StartFunding Finish
$213,78919841984
GNo:185001980

Colorectal Cancer$105,000
Funding Body: University of Sydney

SchemeRole
SharedChief Investigator
Total AmountFunding StartFunding Finish
$105,00019841994
GNo:185001988
Edit

Research Supervision

Number of current supervisions2
Total current UoN Masters EFTSL0.5
Total current UoN PhD EFTSL0.34

For supervisions undertaken at an institution other that the University of Newcastle, the institution name is listed below the program name.

Current Supervision

CommencedProposed
Completion
ProgramSupervisor TypeResearch Title
20142017PhD(Magnetic Resonance in Med)Principal SupervisorMagnetic Resonance Spectroscopy (MRS) to Document Changes in Neurochemistry
20132015M Philosophy (Med RadiationSc)Principal SupervisorTo Study the Use of MRI Spectroscopy to Monitor the Effects of Head Injuries and Post Traumatic Stress Disorder
Edit

Professor Carolyn Mountford

Work Phone(02) 4921 5671
Fax(02) 4921 7744
Email
PositionProfessor of Radiology
Centre for MR in Health
School of Health Sciences
Faculty of Health and Medicine
The University of Newcastle, Australia
Office
URL:www.newcastle.edu.au/profile/carolyn-mountford